TECH FY 2020 Earnings Report — Bio-Techne Corporation Revenue & Financial Results | Market Cap Arena

Bio-Techne CorporationTECH

FY 2020 Earnings

Reported August 26, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$739M	—	$714M	—	3.5%
Op. Income	$157M	—	$126M	—	25.4%
Gross Margin	65.4%	—	66.3%	—	-0.9pp
Net Margin	31.0%	—	13.5%	—	17.6pp
EPS (Diluted)	$1.45	—	$0.62	—	133.9%
Free Cash Flow	$153M	—	$156M	—	-1.8%

Revenue Flow

Item	Amount
REVENUE	$739M
Cost of Revenue	$255M
GROSS PROFIT	$483M
R&D Expenses	$65M
Selling & Marketing	$0
General & Administrative	$241M
SG&A Expenses	$241M
Other Expenses	$20M
Operating Expenses	$326M
Cost & Expenses	$581M
OPERATING INCOME	$157M
Interest Income	$605.0K
Interest Expense	$19M
Other Income/Expenses	$119M
INCOME BEFORE TAX	$276M
Income Tax Expense	$47M
Net Income from Continuing Ops	$229M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$229M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$229M
D&A	$83M
EBIT	$296M
EBITDA	$378M
EPS	$2
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$739M
Cost of Revenue	$255M
GROSS PROFIT	$483M
R&D Expenses	$65M
Selling & Marketing	$0
General & Administrative	$241M
SG&A Expenses	$241M
Other Expenses	$20M
Operating Expenses	$326M
Cost & Expenses	$581M
OPERATING INCOME	$157M
Interest Income	$605.0K
Interest Expense	$19M
Other Income/Expenses	$119M
INCOME BEFORE TAX	$276M
Income Tax Expense	$47M
Net Income from Continuing Ops	$229M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$229M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$229M
D&A	$83M
EBIT	$296M
EBITDA	$378M
EPS	$2
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$229M
Depreciation & Amortization	$83M
Stock-Based Compensation	$32M
Deferred Income Tax	$13M
Other Non-Cash Items	-$147M
Change in Working Capital	-$5M
OPERATING CASH FLOW	$205M
Capital Expenditure	-$52M
Acquisitions (Net)	$2M
Purchases of Investments	-$70M
Sales/Maturities of Investments	$147M
Other Investing Activities	$0
NET CASH FROM INVESTING	$27M
Net Debt Issuance	-$149M
Common Stock Repurchased	-$50M
Common Dividends Paid	-$49M
Other Financing Activities	$64M
NET CASH FROM FINANCING	-$184M
FREE CASH FLOW	$153M
Net Change in Cash	$46M

Balance Sheet

Item	Amount
Cash & Equivalents	$147M
Short-Term Investments	$124M
Net Receivables	$123M
Inventory	$103M
Other Current Assets	$24M
TOTAL CURRENT ASSETS	$521M
PP&E (Net)	$248M
Goodwill	$728M
Intangible Assets	$517M
Long-Term Investments	$0
Tax Assets	$0
Other Non-Current Assets	$14M
TOTAL NON-CURRENT ASSETS	$1.5B
TOTAL ASSETS	$2.0B
Account Payables	$23M
Short-Term Debt	$13M
Deferred Revenue	$13M
Other Current Liabilities	$0
TOTAL CURRENT LIABILITIES	$107M
Long-Term Debt	$344M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$101M
Other Non-Current Liabilities	$27M
TOTAL NON-CURRENT LIABILITIES	$540M
TOTAL LIABILITIES	$646M
Common Stock	$385.0K
Additional Paid-In Capital	$421M
Retained Earnings	$1.1B
Treasury Stock	$0
Accum. Other Comp. Income	-$97M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$1.4B
Minority Interest	$0
TOTAL EQUITY	$1.4B
TOTAL LIABILITIES & EQUITY	$2.0B
Total Debt	$434M
Net Debt	$287M